CARDIFF ONCOLOGY, INC. Revenue Recognition, Milestone Method, Revenue Recognized
CARDIFF ONCOLOGY, INC. (CRDF) reported Revenue Recognition, Milestone Method, Revenue Recognized of $150.00 thousand for the 176-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Notes
us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized · last filed 2015-03-12
- CARDIFF ONCOLOGY, INC. revenue recognition, milestone method, revenue recognized for the quarter ending 2012-09-30 was $150.00K.
- CARDIFF ONCOLOGY, INC. revenue recognition, milestone method, revenue recognized for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- CARDIFF ONCOLOGY, INC. revenue recognition, milestone method, revenue recognized for fiscal 2012 was $150.00K.
- CARDIFF ONCOLOGY, INC. revenue recognition, milestone method, revenue recognized for fiscal 2011 was $0.00.
| Period end | Revenue Recognition, Milestone Method, Revenue Recognized 3 month | Revenue Recognition, Milestone Method, Revenue Recognized 9 month | Revenue Recognition, Milestone Method, Revenue Recognized 12 month | Revenue Recognition, Milestone Method, Revenue Recognized 158 month | Revenue Recognition, Milestone Method, Revenue Recognized 161 month | Revenue Recognition, Milestone Method, Revenue Recognized 164 month | Revenue Recognition, Milestone Method, Revenue Recognized 167 month | Revenue Recognition, Milestone Method, Revenue Recognized 170 month | Revenue Recognition, Milestone Method, Revenue Recognized 173 month | Revenue Recognition, Milestone Method, Revenue Recognized 176 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $150.00K 10-Q · filed 2014-05-12 | |||||||||
| 2013-12-31 | $0.00 10-K · filed 2014-03-17 | $150.00K 10-K · filed 2014-03-17 | ||||||||
| 2013-09-30 | $150.00K 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $150.00K 10-Q · filed 2013-08-14 | |||||||||
| 2013-03-31 | $150.00K 10-Q · filed 2013-05-14 | |||||||||
| 2012-12-31 | $150.00K 10-K · filed 2015-03-12 | $150.00K 10-K · filed 2013-04-01 | ||||||||
| 2012-09-30 | $150.00K 10-Q · filed 2013-11-14 | $150.00K 10-Q · filed 2013-11-14 | $150.00K 10-Q · filed 2012-11-14 | |||||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |